for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Siemens Healthineers AG

SHLG.DE

現在値

46.77EUR

変化

-0.03(-0.06%)

出来高

560,133

本日のレンジ

46.53

 - 

47.00

52週レンジ

35.58

 - 

49.98

∙ 約20分前の相場を表示しています。

適時開示

Siemens Healthineers Says Determines Placement Price For New Shares From Capital Increase

March 24 (Reuters) - Siemens Healthineers AG <SHLG.DE>::DGAP-ADHOC: SIEMENS HEALTHINEERS AG: SIEMENS HEALTHINEERS DETERMINES THE PLACEMENT PRICE FOR THE NEW SHARES FROM THE CAPITAL INCREASE.SIEMENS HEALTHINEERS-TO INCREASE SHARE CAPITAL THROUGH PARTIAL UTILIZATION OF AUTHORIZED CAPITAL UNDER EXCLUSION OF SHAREHOLDERS' SUBSCRIPTION RIGHTS.SHARES WERE PLACED AT A PLACEMENT PRICE OF EUR 44.10 PER SHARE.INCREASE ITS SHARE CAPITAL FROM EUR 1,075,000,000 BY EUR 53,000,000 TO EUR 1,128,000,000.APPROXIMATELY 16.2% OF OFFER SIZE WAS ALLOCATED TO QATAR INVESTMENT AUTHORITY (QIA).

Siemens Healthineers AG Primary ABB Books Are Closed - Bookrunner

March 24 (Reuters) - Siemens Healthineers AG <SHLG.DE>::BLOCKTRADE-SIEMENS HEALTHINEERS AG PRIMARY ABB: BOOKRUNNER SAYS BOOKS ARE CLOSED, ALLOCATIONS WILL BE COMMUNCIATED TOMORROW MORNING BEFORE MARKET OPEN.

Siemens Healthineers Primary ABB Orders Below EUR44.10 Risk Missing - Bookrunner

March 24 (Reuters) - :BLOCKTRADE - SIEMENS HEALTHINEERS PRIMARY ABB: BOOKRUNNER SAYS ORDERS BELOW EUR44.10 RISK MISSING; BOOKS CLOSING AT 8:00PM UKT / 9:00PM CET.Further company coverage: SHLG.DE. ((Reuters.Briefs@thomsonreuters.com;)).

Siemens Healthineers Launches Cash Capital Increase

March 24 (Reuters) - SIEMENS HEALTHINEERS AG <SHLG.DE>::LAUNCHES CASH CAPITAL INCREASE WITH EXCLUSION OF SHAREHOLDERS' SUBSCRIPTION RIGHTS THROUGH ACCELERATED BOOKBUILDING.TARGETING GROSS PROCEEDS OF APPROXIMATELY EUR 2.3 BILLION.NEW SHARES WILL CARRY DIVIDEND RIGHTS AS FROM OCTOBER 1, 2020.SHARE CAPITAL OF SIEMENS HEALTHINEERS WILL BE INCREASED BY ISSUING NEW NO‐PAR VALUE ORDINARY REGISTERED SHARES AGAINST CASH CONTRIBUTIONS UNDER EXCLUSION OF SHAREHOLDERS' SUBSCRIPTION RIGHTS.DELIVERY OF NEW SHARES IS SCHEDULED FOR MARCH 31, 2021.

Varian Announces CEO Succession Plan

March 2 (Reuters) - Varian Medical Systems Inc <VAR.N>::VARIAN ANNOUNCES CEO SUCCESSION PLAN.VARIAN MEDICAL SYSTEMS INC - DOW WILSON TO RETIRE AS CEO.VARIAN MEDICAL SYSTEMS INC - WILSON WILL BE SUCCEEDED BY CHRIS TOTH AS CEO.VARIAN MEDICAL SYSTEMS INC - WILSON WILL RETIRE UPON SUCCESSFUL COMPLETION OF PROPOSED COMBINATION OF VARIAN AND SIEMENS HEALTHINEERS AG.

Siemens Healthineers Says CFIUS Clears Transaction of Planned Merger With Varian

Nov 24 (Reuters) - Siemens Healthineers AG <SHLG.DE>::CFIUS CONCLUDES REVIEW OF PLANNED MERGER WITH VARIAN AND CLEARS TRANSACTION.CFIUS DETERMINED THAT THERE WERE NO UNRESOLVED NATIONAL SECURITY ISSUES WITH RESPECT TO THE TRANSACTION.CO STILL EXPECTS TO CLOSE THE MERGER WITH VARIAN IN THE FIRST HALF OF CALENDAR YEAR 2021.Further company coverage: <SHLG.DE>. (Berlin Speed Desk). ((frankfurt.newsroom@thomsonreuters.com;)).

Siemens Healthineers Says SARS-COV-2 IGG Antibody Test Has Proven To Measure Neutralizing Antibodies

Nov 18 (Reuters) - SIEMENS HEALTHINEERS AG <SHLG.DE>::IS FIRST LEADING DIAGNOSTICS COMPANY OFFERING A QUANTITATIVE COVID-19 TEST TO MEASURE NEUTRALIZING ANTIBODIES.SARS-COV-2 IGG ANTIBODY TEST, AVAILABLE UNDER CE MARK, HAS PROVEN TO MEASURE NEUTRALIZING ANTIBODIES. COMPANY HAS SUBMITTED TO FDA UNDER EUA.AS SARS-COV-2 VACCINES BECOME AVAILABLE, SIEMENS HEALTHINEERS IS READY WITH FULLY AUTOMATED ANTIBODY TESTS THAT CAN BE USED HELP INFORM WHETHER BROAD VACCINATION PROGRAMS ARE WORKING.RELIABLE ANTIBODY TESTS ARE A VALUABLE TOOL TO MEASURE EFFECTIVENESS OF VACCINES.Further company coverage: SHLG.DE. (Gdansk Newsroom). ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;)).

Healthineers See FY COVID-19 Antigen Test Sales Of €100 Mln

Nov 2 (Reuters) - Siemens Healthineers AG <SHLG.DE>::PLANS TO GENERATE REVENUES OF AROUND 100 MILLION EUR WITH CORONAVIRUS ANTIGEN TESTS IN FY 2020/2021.WE GENERATED REVENUES IN HIGH DOUBLE DIGIT MILLION EURO AMOUNT WITH CORONAVIRUS PCR TESTS IN FY 2019/2020.NO TIME PRESSURE FOR SECOND CAPITAL INCREASE FOR VARIAN ACQUISITION.

Varian Reports Results For Fourth Quarter Of Fiscal Year 2020

Oct 27 (Reuters) - Varian Medical Systems Inc <VAR.N>::VARIAN REPORTS RESULTS FOR FOURTH QUARTER OF FISCAL YEAR 2020.Q4 NON-GAAP EARNINGS PER SHARE $1.12.Q4 GAAP EARNINGS PER SHARE $0.83.Q4 EARNINGS PER SHARE ESTIMATE $1.02 -- REFINITIV IBES DATA.QTRLY REVENUES $850.5 MILLION VERSUS $878.9 MILLION.Q4 REVENUE VIEW $813.0 MILLION -- REFINITIV IBES DATA.

Siemens Healthineers Receives U.S. Antitrust Clearance For Proposed Merger With Varian

Oct 23 (Reuters) - Siemens Healthineers AG <SHLG.DE>::ANNOUNCED TODAY THAT THE ANTITRUST-RELATED CONDITION PRECEDENT TO ITS PROPOSED MERGER WITH VARIAN MEDICAL SYSTEMS, INC HAS BEEN MET IN THE U.S..U.S. FEDERAL TRADE COMMISSION HAS PERMITTED THE TRANSACTION TO PROCEED.SIEMENS HEALTHINEERS STILL EXPECTS TO CLOSE THE MERGER WITH VARIAN IN THE FIRST HALF OF CALENDAR YEAR 2021.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up